Article Information
History
- December 15, 2021.
Article Versions
- Version 1 (December 13, 2021 - 08:43).
- You are currently viewing Version 2 of this article (December 15, 2021 - 11:01).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Christopher McMaster1,3,*,
- Julia Chan2,
- David FL Liew1,2,
- Elizabeth Su1,
- Albert G Frauman1,2,
- Wendy W Chapman3 and
- Douglas EV Pires3
- 1Department of Clinical Pharmacology & Therapeutics, Austin Health, Melbourne, Victoria, Australia
- 2Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
- 3The Centre for Digital Transformation of Health, University of Melbourne, Melbourne, Victoria, Australia
- ↵*christopher.mcmaster{at}austin.org.au
Posted December 15, 2021.
Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions
